close
This ad will auto close in 10 seconds
FDI up to 74% in brownfield pharma under automatic route

FDI up to 74% in brownfield pharma under automatic route

The government today allowed up to 74 percent foreign direct investment in the existing pharmaceutical companies through automatic route, with an aim to promote the sector.

Big boost for economy! Modi govt approves 100% FDI in defence, civil aviation, food and pharma sectors

Big boost for economy! Modi govt approves 100% FDI in defence, civil aviation, food and pharma sectors

With these changes, India is now the most open economy in the world for FDI, the government said.

 

 

Govt to commission study on impact of FDI in pharma

Govt to commission study on impact of FDI in pharma

The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.

CCEA clears Glenmark, Aurobindo proposals worth Rs 4,187 cr

Pharmaceutical majors Glenmark and Aurobindo's foreign investment proposals, worth Rs 4,187 crore, were approved by the government Tuesday.

FDI in pharma doubled during Apr-Dec

FDI in drugs and pharmaceuticals was USD 589 million in the April-December period of 2012-13, according to the latest data of the Department of Industrial Policy and Promotion.

Govt retains 100% FDI in existing pharma units

Government Wednesday decided to retain the policy of allowing 100 percent foreign investment in the existing pharma firms, brushing aside concerns about non- availability of affordable drugs in view of MNCs takeovers.

FDI in pharma sector jumps 86.5% during April-Oct period

FDI in the pharmaceutical sector jumped by 86.5 percent to USD 1.08 billion during April- October period of the current fiscal amid concerns over continuous mergers and acquisitions of domestic drug makers by multinationals.

Cabinet likely to decide on FDI in pharma, housing today

With serious concerns being raised from various departments regarding the acquisition of Indian drug firms by global multinational entities, the government is likely to consider reducing the foreign direct investment cap in the pharma sector.

FDI policy in pharma set for major overhaul

The government is set to make major changes in the current FDI policy in the pharmaceuticals sector to protect domestic generic industry in the wake of increasing acquisitions of homegrown companies by foreign players.

Govt to soon finalise FDI policy on pharma sector

Finance Minister P Chidambaram on Monday said the government will soon finalise the foreign investment policy on brownfield pharmaceutical projects, paving the way for clearance of held-up proposals.

FIPB clears 6 pharma proposals worth Rs 855 cr

The Foreign Investment Promotion Board (FIPB) Monday cleared six proposals envisaging investments of Rs 855 crore in the pharmaceutical sector, including one by Fresenius Kabi.

More clarity on FDI in pharma sector soon: PM

Prime Minister Manmohan Singh Saturday said that the government is trying to bring greater clarity on allowing foreign capital inflows in the domestic pharma sector.

Pharma industry unhappy with Govt decision on FDI

Pharmaceutical industry Tuesday criticised the government's decision to make it mandatory for all foreign investments in existing domestic pharma firms to be cleared by the FIPB.

All FDI in domestic pharma cos to be cleared by FIPB

The government Monday decided that all foreign investments in existing domestic pharma firms should be allowed only after clearance by the FIPB, amid mounting concerns over availability of affordable essential drugs in the wake of multinationals acquiring local companies.